Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.8K Hold
740
0.01% 409
2026
Q1
$40.8K Hold
740
0.01% 397
2025
Q4
$36.3K Hold
740
0.01% 401
2025
Q3
$31.9K Hold
740
﹤0.01% 417
2025
Q2
$28.4K Hold
740
﹤0.01% 413
2025
Q1
$28.7K Sell
740
-25
-3% -$915 ﹤0.01% 406
2024
Q4
$25.9K Buy
+765
New +$27.5K ﹤0.01% 413

Other funds holding GSK

Crews Bank & Trust's GSK Position: Q2 2026 in Review

Crews Bank & Trust held its GSK (GSK) position steady in Q2 2026 at 740 shares worth $38.8K. The position accounts for 0.01% of the portfolio, ranked #409.

Crews Bank & Trust first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $40.8K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Crews Bank & Trust held 740 shares of GSK worth $38.8K as of Q2 2026.
  • Crews Bank & Trust left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #409 holding.
  • Crews Bank & Trust first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Crews Bank & Trust's GSK position peaked at $40.8K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.